Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Lungpacer Medical today announced positive results from a Phase 1 clinical study evaluating its neurostimulation technology ...

During a pulmonary angiogram, you may feel the following normal sensations: A brief, sharp stick with the catheter insertion ... pulmonary artery stenosis, and aneurysms. The healthcare provider ...

Catheterization is particularly useful in the diagnosis of occult systemic to pulmonary shunts, congenital heart disease, and distal pulmonary artery stenosis.

Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana thrombectomy system in treating acute pulmonary embolism (PE) patients. TriStar ...

Procedures include bronchoscopy, central line placement, arterial line placement, pulmonary artery catheterization, chest tube insertion, thoracentesis, lumbar puncture, paracentesis and endotracheal ...

These treatment options are listed as follows: Balloon angioplasty. During this procedure, your doctor places a tiny, soft plastic tube called a catheter into the artery, usually in the groin, and ...

In the human model, 38 patients with PAH underwent 18 F-FAPI PET imaging, with right heart catheterization and ... 18 F-FAPI in the right heart and pulmonary artery of patients decreased ...

A transradial approach for cerebral angiography was less effective than the transfemoral route in achieving an accurate diagnostic success rate.

After 21 d of hypoxia, the mean pulmonary artery pressure was measured by cardiac catheterization. The plasma H 2 S level and production of H 2 S in the lung tissues were determined by using a ...

Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...

F-FAPI PET -- can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing physicians with an early marker for disease progression. This approach ...